Qureight
Qureight accelerates clinical trial development at key decision points through data curation and AI-powered decision making. They work with pharmaceutical companies, contract research organisations and hospitals to curate data and help the best drugs get approved: so they can be given to patients who need them the most. Qureight are currently focused on lung and heart disease.
| Trading name | Qureight |
|---|---|
| Sector | HeathTech |
| Founders | Dr Muhunthan Thillai & Dr Alessandro Ruggiero |
| Date invested | 19/03/2024 |
| Date founded | 04/01/2018 |
| Status | Current Investment |
Image